慢性肾脏病中小胶质细胞IL-1β的非经典成熟机制
本研究探讨慢性肾脏病(CKD)中小胶质细胞IL-1β成熟的机制。通过单细胞分析、基因修饰小鼠模型和体外模型,发现CKD中小胶质细胞IL-1β成熟不依赖NLRP3-caspase-1,而由组织蛋白酶C-caspase-8介导的非经典途径完成,敲除组织蛋白酶C或caspase-8可阻断IL-1β成熟。该非经典途径可能是治疗CKD认知障碍的潜在靶点。
要点
- CKD中小胶质细胞IL-1β成熟不依赖caspase-1,靶向caspase-1不能改善认知。
- 组织蛋白酶C-caspase-8介导非经典IL-1β成熟,敲除任一分子可阻断。
- 该非经典途径可能是CKD认知障碍的治疗靶点,糖尿病中也可能存在。
核心结论
- CKD中小胶质细胞IL-1β成熟通过组织蛋白酶C-caspase-8非经典途径,不依赖NLRP3-caspase-1。
- 非经典IL-1β成熟途径是治疗CKD认知障碍的潜在靶点。
研究设计与样本
- 结合单细胞分析、原位分析、基因修饰小鼠模型(包括新建Cre-LoxP模型)和体外模型。
主要发现
- CKD小鼠脑内存在NLRP3炎症小体激活,组成性NLRP3缺陷可防止CKD诱导的认知障碍。
- caspase-1不是小胶质细胞IL-1β成熟所必需,小胶质细胞靶向caspase-1缺陷不改善CKD小鼠认知。
- CKD中小胶质细胞激活诱导组织蛋白酶C-caspase-8介导的非经典IL-1β成熟,敲除组织蛋白酶C或caspase-8可阻断。
- 初步分析提示非经典小胶质细胞IL-1β成熟也见于糖尿病。
临床怎么用
- 在CKD认知障碍中,不应仅靶向caspase-1,需考虑组织蛋白酶C-caspase-8非经典途径。
- 组织蛋白酶C或caspase-8可能成为治疗CKD认知障碍的新靶点。
局限性
- 非经典IL-1β成熟在糖尿病中的证据仅为初步分析,需进一步验证。
- 研究主要基于小鼠模型和体外实验,人体数据尚未报道。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Organ transplantation reverses cognitive impairment in chronic kidney disease (CKD), indicating that cognitive impairment driven by CKD is therapeutically amendable. We recently demonstrated that impaired cognition in CKD is linked to interleukin-1β (IL-1β) release from microglia and IL-1 receptor type 1 signalling in neuronal cells, thereby identifying a signalling pathway that can be exploited therapeutically. However, the mechanism of IL-1β maturation in microglia in CKD remains unknown. We hypothesized that microglia cells require caspase-1 for CKD-driven cognitive impairment. METHODS: We used a combination of single-cell analyses, in situ analyses, genetically modified mouse models (including newly generated Cre-LoxP mouse models) and in vitro models. The current study builds on a recently identified intercellular cross-talk between microglia and neurons that impairs cognition in CKD. RESULTS: Here we show that despite NLRP3 inflammasome activation in the brain and protection of mice with constitutive NLRP3 deficiency from CKD-induced cognitive impairment, caspase-1 is not required for IL-1β maturation in microglia and targeted caspase-1 deficiency in microglia does not improve cognition in CKD mice. These data indicate that IL-1β maturation in microglia is independent of the NLRP3-caspase-1 interaction in CKD. Indeed, microglia activation in CKD induces noncanonical, cathepsin C-caspase-8-mediated IL-1β maturation. Depletion of cathepsin C or caspase-8 blocks IL-1β maturation in microglia. Preliminary analyses suggest that noncanonical microglia IL-1β maturation occurs also in diabetes mellitus. CONCLUSION: These results identify a noncanonical IL-1β-maturation pathway as a potential therapeutic target to combat microglia-induced neuronal dysfunction in CKD and possibly other peripheral diseases.
引用
- Zimmermann S, Mathew A, Bondareva O, et al. Noncanonical microglial IL-1β maturation in chronic kidney disease. Nephrol Dial Transplant. 2025. PMID: 39496522. doi:10.1093/ndt/gfae239
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。